Legal Representation
Attorney
Danielle I. Mattessich
USPTO Deadlines
Next Deadline
27 days remaining
NOA E-Mailed - SOU Required
Due Date
August 04, 2025
Extension Available
Until February 04, 2026
Application History
8 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 17, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 2, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 2, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Biological preparations for the treatment of eye conditions, namely, to slow down loss of eye sight due to wet age macular degeneration (wet AMD), diabetic macular edema (DME) and retinal vein occlusion (RVO); Biological preparations for the treatment of eye diseases; Biological preparations for use in intravitreal medicinal therapy; Pharmaceutical preparations for the treatment of wet AMD, DME and RVO; Pharmaceutical preparations for the treatment of eye diseases; Pharmaceutical preparations for slowing the growth of blood vessels in the eye, namely, anti-VEGF intravitreal injections; Pharmaceutical preparations for slowing down blindness due to proliferation of blood vessels in the eye
Classification
International Classes
005